Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cariogenic bacteria metabolic process refers to the set of metabolic activities performed mainly by *Streptococcus mutans* and similar oral bacteria, which convert dietary carbohydrates into acids—especially lactic acid—under acidic and nutrient-variable conditions. This acid production diminishes local pH, leading to demineralization of tooth enamel and dentine and ultimately resulting in dental caries. Bacteria have adaptive mechanisms to survive nutrient depletion, including polysaccharide storage and switching fermentative pathways. This process is central to caries pathology but is not a single molecular target; rather, it describes microbial metabolic attributes that underlie disease development.
Inhibition of glycolysis and acid production; Disruption of carbohydrate uptake/metabolism; Enhancement of non-cariogenic pathways or competitive flora.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cariogenic bacteria metabolic process.